Unknown

Dataset Information

0

Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact.


ABSTRACT: Transcranial Doppler (TCD) detects stroke risk in patients with sickle cell anemia (SCA). Hydroxyurea therapy has the ability to induce increased levels of fetal hemoglobin in sickle cells thus decreasing tendency for red cell sickling. This study aimed to evaluate TCD findings in SCA patients on hydroxyurea and correlate the time-averaged mean velocity (TAMV) with their hematological parameters. Forty SCA patients of both sexes, aged 16-22 years with no history of stroke were screened with TCD for an elevated TAMV, divided into: Group T (20 patients on blood transfusion); and Group H (20 patients on daily hydroxyurea). For all, full medical history, clinical examination, hemoglobin, hematocrit, leukocytes, platelets, fetal hemoglobin and sickling test, in addition TCD to describe the pattern of cerebral blood flow abnormalities were done. TAMV in all cerebral arteries were significantly higher in Group T than Group H, the highest TAMV (147.5 ± 57.09 cm/s) was found in the right middle cerebral artery and correlated negatively with hematocrit in Groups H (P < 0.001). There were 2 (10%) abnormal TAMV results and 5 (25%) conditional in Group T, while all results were normal in Group H. Hydroxyurea therapy may lower TCD velocities and prevent the risk of primary stroke in SCA patients.

SUBMITTER: Moeen SM 

PROVIDER: S-EPMC5786611 | biostudies-other | 2018 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact.

Moeen Sawsan M SM   Thabet Ahmad F AF   Hasan Hosam A HA   Saleh Medhat A MA  

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 20170408 1


Transcranial Doppler (TCD) detects stroke risk in patients with sickle cell anemia (SCA). Hydroxyurea therapy has the ability to induce increased levels of fetal hemoglobin in sickle cells thus decreasing tendency for red cell sickling. This study aimed to evaluate TCD findings in SCA patients on hydroxyurea and correlate the time-averaged mean velocity (TAMV) with their hematological parameters. Forty SCA patients of both sexes, aged 16-22 years with no history of stroke were screened with TCD  ...[more]

Similar Datasets

| S-EPMC4126329 | biostudies-literature
| S-EPMC6439675 | biostudies-literature
| S-EPMC4715740 | biostudies-literature
| S-EPMC5724392 | biostudies-literature
| S-EPMC5868345 | biostudies-literature
| S-EPMC4924807 | biostudies-literature
| S-EPMC4074648 | biostudies-literature
| S-EPMC4179098 | biostudies-literature
| S-EPMC2794994 | biostudies-literature
| S-EPMC1569824 | biostudies-other